World's Best Scientists 2026 revealed!
Hartmut Döhner

Hartmut Döhner

Award Badge
Best Scientists
2025
Award Badge
Medicine
Germany
2026

D-Index & Metrics

Best Scientists

D-Index
172
Citations
131719
World Ranking
800
National Ranking
36

Medicine

D-Index
175
Citations
142121
World Ranking
422
National Ranking
17

Research.com Recognitions

  • 2026 - Research.com Medicine in Germany Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2023 - Research.com Medicine in Germany Leader Award

Overview

Hartmut Döhner is affiliated with the University of Ulm in Germany and has made extensive contributions in the fields of medicine, particularly hematology, molecular biology, and genetics. Their work primarily focuses on hematologic malignancies, including acute and chronic leukemias and myeloproliferative neoplasms.

The scientist's main research topics include:

  • Acute Myeloid Leukemia Research
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment
  • Acute Lymphoblastic Leukemia Research
  • Histone Deacetylase Inhibitors Research
  • Protein Degradation and Inhibitors
  • Chronic Lymphocytic Leukemia Research

Frequent co-authors collaborating with Hartmut Döhner comprise:

  • Konstanze Döhner
  • Michael Heuser
  • Lars Bullinger
  • Andrew H. Wei
  • Felicitas Thol

Notable recent publications by Hartmut Döhner include:

  • Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN, 2022, Blood

Additional significant papers related to their field but led by other authors include:

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia, 2020, New England Journal of Medicine
  • International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data, 2022, Blood
  • Ivosidenib and Azacitidine in IDH1-Mutated Acute Myeloid Leukemia, 2022, New England Journal of Medicine
  • Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission, 2020, New England Journal of Medicine

Hartmut Döhner's frequent publication venues include:

  • Blood
  • HemaSphere
  • Leukemia
  • Clinical Lymphoma Myeloma & Leukemia
  • Journal of Clinical Oncology

In total, Hartmut Döhner has contributed significantly to medicine, with a publication record that encompasses over 500 works, focused largely on hematology and molecular biology. Their research integrates clinical, morphologic, and genomic data to advance understanding and treatment of myeloid neoplasms and leukemias.

Best Publications

  • Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

    Hartmut Döhner;Elihu Estey;David Grimwade;Sergio Amadori

  • Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute–Working Group 1996 guidelines

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia

    Hartmut Döhner;Stephan Stilgenbauer;Axel Benner;Elke Leupolt

  • Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.

    Hartmut Dohner;Elihu H. Estey;Sergio Amadori;Frederick R. Appelbaum

  • Genomic Classification and Prognosis in Acute Myeloid Leukemia

    Elli Papaemmanuil;Moritz Gerstung;Lars Bullinger;Verena I Gaidzik

  • Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

    Michael Hallek;K. Fischer;Gunter Fingerle-Rowson;A.M. Fink

  • Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia

    Richard F. Schlenk;Konstanze Döhner;Jürgen Krauter;Stefan Fröhling

  • Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a FLT3 Mutation

    Richard M. Stone;Sumithra J. Mandrekar;Ben L. Sanford;Kristina Laumann

  • Azacitidine and Venetoclax in Previously Untreated Acute Myeloid Leukemia

    Courtney D DiNardo;Brian A Jonas;Vinod Pullarkat;Michael J Thirman

  • Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions

    Valentin Goede;Kirsten Fischer;Raymonde Busch;Anja Engelke

  • iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL

    Michael Hallek;Bruce D. Cheson;Daniel Catovsky;Federico Caligaris-Cappio

  • Acute myeloid leukaemia

    Elihu Estey;Hartmut Döhner

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Matrix‐based comparative genomic hybridization: Biochips to screen for genomic imbalances

    Sabina Solinas-Toldo;Stefan Lampel;Stephan Stilgenbauer;Jeremy Nickolenko

  • Use of gene-expression profiling to identify prognostic subclasses in adult acute myeloid leukemia.

    Lars Bullinger;Konstanze Döhner;Eric Bair;Stefan Fröhling

  • Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

    Stefan Fröhling;Richard F. Schlenk;Jochen Breitruck;Axel Benner

  • International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts

    Hervé Dombret;John F. Seymour;Aleksandra Butrym;Agnieszka Wierzbowska

  • Mutations driving CLL and their evolution in progression and relapse.

    Dan A. Landau;Eugen Tausch;Amaro N. Taylor-Weiner;Chip Stewart

  • Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet

    Miguel A. Sanz;David Grimwade;Martin S. Tallman;Bob Lowenberg

  • VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia

    Alexander Kröber;Till Seiler;Till Seiler;Axel Benner;Axel Benner;Lars Bullinger;Lars Bullinger

Frequent Co-Authors

Konstanze Döhner
Konstanze Döhner University of Ulm
Richard F. Schlenk
Richard F. Schlenk University Hospital Heidelberg
Stephan Stilgenbauer
Stephan Stilgenbauer University of Ulm
Lars Bullinger
Lars Bullinger Charité - University Medicine Berlin
Arnold Ganser
Arnold Ganser Hannover Medical School
Michael Hallek
Michael Hallek University of Cologne
Peter Lichter
Peter Lichter German Cancer Research Center
Michael Heuser
Michael Heuser Hannover Medical School
Michael Kneba
Michael Kneba Kiel University
Axel Benner
Axel Benner German Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in healthcare but not pursuing a traditional MD path, there are many flexible online degree options that open the door to rewarding careers. Online programs can be ideal for working professionals or students who need a more adaptable schedule.

If you're considering pharmacy, an online pharmd program offers advanced education and can lead to high-demand roles in community, hospital, or clinical pharmacy settings.

The ever-growing field of health data and technology is also within reach. A health information technology online degree prepares graduates to manage healthcare data, support electronic health records, and ensure regulatory compliance in hospitals and clinics.

For administrative careers, consider a medical billing and coding certification online. This field is essential for medical offices and insurance companies, ensuring accuracy in billing and documentation.

Nursing professionals seeking to advance can explore the cheapest online fnp program options, which allow registered nurses to step up into primary care and specialized roles without leaving their job.

These online degrees and certifications not only offer flexibility but also provide pathways into some of the fastest-growing sectors in healthcare.

Best Scientists Citing Hartmut Döhner

Trending Scientists

Recently Published Articles